These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 29559699)
1. Characterization of a murine model of non-lethal, symptomatic dengue virus infection. Sarathy VV; White M; Li L; Kaiser JA; Campbell GA; Milligan GN; Bourne N; Barrett ADT Sci Rep; 2018 Mar; 8(1):4900. PubMed ID: 29559699 [TBL] [Abstract][Full Text] [Related]
2. A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease. Sarathy VV; White M; Li L; Gorder SR; Pyles RB; Campbell GA; Milligan GN; Bourne N; Barrett AD J Virol; 2015 Jan; 89(2):1254-66. PubMed ID: 25392217 [TBL] [Abstract][Full Text] [Related]
3. Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse model. Sarathy VV; Infante E; Li L; Campbell GA; Wang T; Paessler S; Robert Beatty P; Harris E; Milligan GN; Bourne N; Barrett ADT J Gen Virol; 2015 Oct; 96(10):3035-3048. PubMed ID: 26296350 [TBL] [Abstract][Full Text] [Related]
4. A lethal model of disseminated dengue virus type 1 infection in AG129 mice. Milligan GN; Sarathy VV; White MM; Greenberg MB; Campbell GA; Pyles RB; Barrett ADT; Bourne N J Gen Virol; 2017 Oct; 98(10):2507-2519. PubMed ID: 28949904 [TBL] [Abstract][Full Text] [Related]
5. A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice. Milligan GN; Sarathy VV; Infante E; Li L; Campbell GA; Beatty PR; Harris E; Barrett AD; Bourne N PLoS One; 2015; 10(5):e0125476. PubMed ID: 25938762 [TBL] [Abstract][Full Text] [Related]
6. Mouse models of dengue virus infection for vaccine testing. Sarathy VV; Milligan GN; Bourne N; Barrett AD Vaccine; 2015 Dec; 33(50):7051-60. PubMed ID: 26478201 [TBL] [Abstract][Full Text] [Related]
8. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines. Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106 [TBL] [Abstract][Full Text] [Related]
9. Acute Systemic Infection with Dengue Virus Leads to Vascular Leakage and Death through Tumor Necrosis Factor-α and Tie2/Angiopoietin Signaling in Mice Lacking Type I and II Interferon Receptors. Phanthanawiboon S; Limkittikul K; Sakai Y; Takakura N; Saijo M; Kurosu T PLoS One; 2016; 11(2):e0148564. PubMed ID: 26844767 [TBL] [Abstract][Full Text] [Related]
10. Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: Proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008. Milligan GN; White M; Zavala D; Pyles RB; Sarathy VV; Barrett ADT; Bourne N Antiviral Res; 2018 Jun; 154():104-109. PubMed ID: 29665374 [TBL] [Abstract][Full Text] [Related]
11. Dengue virus infects the mouse eye following systemic or intracranial infection and induces inflammatory responses. Norbury AJ; Calvert JK; Al-Shujairi WH; Cabezas-Falcon S; Tang V; Ong LC; Alonso SL; Smith JR; Carr JM J Gen Virol; 2020 Jan; 101(1):79-85. PubMed ID: 31774391 [TBL] [Abstract][Full Text] [Related]
12. An iminosugar with potent inhibition of dengue virus infection in vivo. Perry ST; Buck MD; Plummer EM; Penmasta RA; Batra H; Stavale EJ; Warfield KL; Dwek RA; Butters TD; Alonzi DS; Lada SM; King K; Klose B; Ramstedt U; Shresta S Antiviral Res; 2013 Apr; 98(1):35-43. PubMed ID: 23376501 [TBL] [Abstract][Full Text] [Related]
13. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice. Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279 [TBL] [Abstract][Full Text] [Related]
14. Sequence diversity of dengue virus type 2 in brain and thymus of infected interferon receptor ko mice: implications for dengue virulence. Dhole P; Nakayama EE; Saito A; Limkittikul K; Phanthanawiboon S; Shioda T; Kurosu T Virol J; 2016 Nov; 13(1):199. PubMed ID: 27903277 [TBL] [Abstract][Full Text] [Related]
15. Maternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver Damage. Martínez Gómez JM; Ong LC; Lam JH; Binte Aman SA; Libau EA; Lee PX; St John AL; Alonso S PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004536. PubMed ID: 27007501 [TBL] [Abstract][Full Text] [Related]
16. A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice. Tan GK; Ng JK; Trasti SL; Schul W; Yip G; Alonso S PLoS Negl Trop Dis; 2010 Apr; 4(4):e672. PubMed ID: 20436920 [TBL] [Abstract][Full Text] [Related]
17. Full-length genome and molecular characterization of dengue virus serotype 2 isolated from an imported patient from Myanmar. Zeng Z; Shi J; Guo X; Mo L; Hu N; Sun J; Wu M; Zhou H; Hu Y Virol J; 2018 Aug; 15(1):131. PubMed ID: 30126417 [TBL] [Abstract][Full Text] [Related]
18. Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models. Tang WW; Grewal R; Shresta S Curr Opin Virol; 2015 Aug; 13():61-6. PubMed ID: 26001278 [TBL] [Abstract][Full Text] [Related]